Stockscreener 앱 받기
89.08
2.07%
1.81
시간 외 거래:
89.08
Guardant Health Inc 주식(GH)의 최신 뉴스
Insider Sell: Musa Tariq Sells Shares of Guardant Health Inc (GH) - GuruFocus
Insider Selling: Guardant Health (NASDAQ:GH) Director Sells 348 Shares of Stock - MarketBeat
Guardant Health (GH) director Tariq Musa sells $30,655 in stock - Investing.com
Guardant Health (NASDAQ: GH) director sells 348 company shares - Stock Titan
3 Reasons to Steer Clear of GH and One Alternative Stock Worth Buying - Bitget
Guardant Health Stock Analysis: Price Rise vs. Financial Risks | 2026News and Statistics - IndexBox
(GH) Risk Channels and Responsive Allocation - Stock Traders Daily
Cathie Wood’s ARK sells Guardant Health stock, buys Arcturus Therapeutics - Investing.com
Director at Guardant Health (GH) receives 232 shares via RSUs - Stock Titan
Guardant Health (NASDAQ: GH) Form 144 shows proposed insider sale of shares - Stock Titan
Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026 - BioSpace
Multiple analysts lift Guardant Health, Inc. (GH) targets on screening and data growth - MSN
Why Guardant Health’s (GH) 2026 Screening Story Reinforced Piper Sandler’s Bullish View - Yahoo Finance UK
Blood tests flag new primary cancers and actionable results in AACR data - Stock Titan
Guardant Health (GH) Co-CEO logs RSU grants, tax withholding and trust share transfer - Stock Titan
Guardant Health (GH) Co-CEO receives RSUs and shifts shares to trust - Stock Titan
Guardant Health (NASDAQ:GH) CFO Sells $261,120.00 in Stock - MarketBeat
Guardant Health (GH) director acquires 249 shares via RSU vesting - Stock Titan
Guardant Health (NASDAQ: GH) CLO gains stock through RSU vesting - Stock Titan
Guardant Health (GH) CIO exercises RSUs and PBRSUs; 6,839 shares withheld for taxes - Stock Titan
Guardant Health (GH) CCO gains shares through RSU vesting and tax withholding - Stock Titan
Guardant Health (GH) CMO exercises RSUs; shares withheld to cover taxes - Stock Titan
Guardant Health (GH) CTO exercises 10,714 PSUs; 5,759 shares withheld for taxes - Stock Titan
Guardant Health (GH) CFO sells shares and reports RSU vesting - Stock Titan
Survey Supports Blood Tests for Colorectal Cancer Screening - CUREtoday.com
Here’s Why Artisan Small Cap Fund Bets on Guardant Health (GH) - Insider Monkey
Guardant Health launches Shield Multi-Cancer Detection Test in APAC market - BioSpectrum Asia
Oncology Molecular Diagnostics Market Growth 2026 | NGS, PCR - openPR.com
Guardant Health Touts Quest Deal for Shield, Guardant360 Growth and FDA Milestones at Leerink Conference - MarketBeat
Algert Global LLC Raises Stock Holdings in Guardant Health, Inc. $GH - MarketBeat
Guardant Health Touts Hypergrowth in Guardant360, Reveal MRD and Shield CRC at Barclays Conference - MarketBeat
Singapore's Guardant Health launches Shield Multi-Cancer Detection (MCD) Test in APAC market - BioSpectrum Asia
[144] Guardant Health, Inc. SEC Filing - Stock Titan
Guardant Health launches multi-cancer blood test in Asia through Manulife partnership - Mugglehead Magazine
Guardant Health, Harris Poll Survey Shows 92% of Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered - National Today
Guardant Health, Inc. $GH Shares Bought by Iron Triangle Partners LP - MarketBeat
Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership - Yahoo Finance
HighVista Strategies LLC Acquires 36,318 Shares of Guardant Health, Inc. $GH - MarketBeat
Fred Alger Management LLC Has $39.89 Million Holdings in Guardant Health, Inc. $GH - MarketBeat
Guardant Health, Inc. $GH Shares Purchased by First Light Asset Management LLC - MarketBeat
Guardant Health Shares Bought by Aquatic Capital Management - National Today
Guardant Health, Inc. $GH Shares Bought by Aquatic Capital Management LLC - MarketBeat
Is Guardant Health’s (GH) Shield Tour Redefining Its Competitive Moat in Cancer Screening? - simplywall.st
Colon cancer awareness drives conversation at Pennzoil 400 - ktnv.com
Manulife Announces Exclusive Partnership with Guardant Health to Bring the Shield Multi-Cancer Detection Test to Customers Across Asia - The Manila Times
Pennzoil 400 crowds draw colorectal cancer screening bus to Las Vegas Motor Speedway - KSNV
Cinctive Capital Management LP Buys Stake in Guardant Health - National Today
Eventide Asset Management LLC Lowers Holdings in Guardant Health, Inc. $GH - MarketBeat
Assessing Guardant Health (GH) Valuation As Shield Screening Momentum Builds With FDA Approval And Nationwide Tour - Yahoo Finance
Cinctive Capital Management LP Buys Shares of 121,130 Guardant Health, Inc. $GH - MarketBeat
Shield Progress Draws Attention To Guardant Health’s Valuation And Risks - Yahoo Finance
Guardant Health (GH) Valuation Check As Shield Across America Expands Colorectal Cancer Screening Reach - simplywall.st
Meridiem Capital Partners LP Cuts Stock Holdings in Guardant Health, Inc. $GH - MarketBeat
Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings - The Motley Fool
Liquid Biopsy Market to Reach US$28.20 Billion by 2033 at 12.8% - openPR.com
New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare - WFMZ.com
Guardant Health, Inc. $GH Shares Bought by Pier Capital LLC - MarketBeat
Guardant Health, Inc. $GH Shares Bought by Franklin Resources Inc. - MarketBeat
Guardant Health (GH) CIO granted 13,632 restricted stock units - Stock Titan
BIAF vs. GH: Which cancer detection stock is the better buy now? - MSN
Guardant Health Is Riding Shield’s Fast Screening Ramp - Finimize
Quest Diagnostics Extends Colorectal Screening Reach With Guardant Shield Partnership - Yahoo Finance
Atika Capital Management LLC Has $8.31 Million Position in Guardant Health, Inc. $GH - MarketBeat
Quest Diagnostics Expands Preventive Reach With Shield Colorectal Blood Test - simplywall.st
Capital International Investors Sells 287,217 Shares of Guardant Health, Inc. $GH - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Guardant Health at Leerink Global Healthcare: Strategic Growth and Partnerships - Investing.com Canada
Guardant Health's Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics - National Today
Guardant Health’s Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics - Yahoo Finance
Hidalgo Medina sells Guardant Health (GH) shares for $118,996 - Investing.com
Hidalgo Medina sells Guardant Health (GH) shares for $118,996 By Investing.com - Investing.com India
0.55%
2.50%
자본화:
|
볼륨(24시간):